Treatment Recommendations for Tardive Dyskinesia.
Ricciardi L, Pringsheim T, Barnes TRE, Martino D, Gardner D, Remington G, Addington D, Morgante F, Poole N, Carson A, Edwards M.
Can J Psychiatry. 2019 Jun;64(6):388-399. doi: 10.1177/0706743719828968. Epub 2019 Feb 21.
Tardive Dyskinesia: Treatment Update.
Arya D, Khan T, Margolius AJ, Fernandez HH.
Curr Neurol Neurosci Rep. 2019 Aug 16;19(9):69. doi: 10.1007/s11910-019-0976-1.
Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis.
Carbon M, Hsieh CH, Kane JM, Correll CU.
J Clin Psychiatry. 2017 Mar;78(3):e264-e278. doi: 10.4088/JCP.16r10832.
Tardive dyskinesia: Epidemiology.
D'Abreu A, Akbar U, Friedman JH.
J Neurol Sci. 2018 Jun 15;389:17-20. doi: 10.1016/j.jns.2018.02.007. Epub 2018 Feb 5.
Tardive dyskinesia: Who gets it and why.
Frei K.
Parkinsonism Relat Disord. 2019 Feb;59:151-154. doi: 10.1016/j.parkreldis.2018.11.017. Epub 2018 Nov 15.
Treatment of Tardive Dyskinesia.
Bashir HH, Jankovic J.
Neurol Clin. 2020 May;38(2):379-396. doi: 10.1016/j.ncl.2020.01.004. Epub 2020 Feb 28.
Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.
Hauser RA, Meyer JM, Factor SA, Comella CL, Tanner CM, Xavier RM, Caroff SN, Lundt L.
CNS Spectr. 2022 Apr;27(2):208-217. doi: 10.1017/S109285292000200X. Epub 2020 Nov 20.
Tardive dyskinesia: Out of the shadows.
Hauser RA, Truong D.
J Neurol Sci. 2018 Jun 15;389:1-3. doi: 10.1016/j.jns.2018.02.009. Epub 2018 Feb 5.
[Tardive dyskinesia].
Zalyalova ZA.
Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(7):25-31. doi: 10.17116/jnevro202312307125.
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
Hauser RA, Factor SA, Marder SR, Knesevich MA, Ramirez PM, Jimenez R, Burke J, Liang GS, O'Brien CF.
Am J Psychiatry. 2017 May 1;174(5):476-484. doi: 10.1176/appi.ajp.2017.16091037. Epub 2017 Mar 21.
